This website is intended for Medical Professionals only. By using this site you confirm that you are a healthcare professional.

News
Physical activity may attenuate ... A new study on menopausal women shows that leisure-time physical ... (17 Sep 2019)
Adolescents with high levels of physical ... Previous cross-sectional studies have reported that physically ... (11 Sep 2019)
Offering children a variety of vegetables ... Variety is key to helping children form preferences for ... (11 Sep 2019)
ADHD medication: how much is too much for a ... When children with ADHD don’t respond well to Methylphenidate ... (11 Sep 2019)
Scientists find psychiatric drugs affect gut ... Scientists have found that antidepressants and other psychiatric ... (11 Sep 2019)

New Glaucoma Procedure Performed in Malta

Rate this item
(0 votes)

On the 15th June, a new glaucoma procedure was performed for the first time in Malta, as part of a surgeon training session organised by Allergan. The new XEN implant forms part of Allergan’s Eyecare portfolio distributed by Vivian Corporation.

glaucoma 2

 

XEN is a simple and effective way to treat glaucoma. The implant consists of a small tube 6mm long and the thickness of a human hair, which is inserted into the eye with a pre-packed injector. This reduces the size of the incision needed. XEN is indicated to reduce eye pressure in patients whose glaucoma is not well-managed with eye drops. It is designed to stay in the eye permanently creating a small pathway to drain fluid away to lower pressure inside the eye.

The surgeons and staff first received training on artificial eyes at St. James Eye Clinic by Allergan’s surgical partner, Dr. Evelina Kotseva. The following morning, a total of 5 patients had the new XEN implants inserted into their eyes. These surgeries were performed by Mr. Mario Vella and Mr. Francis Carbonaro, at Mater Dei Hospital. Katrine Agius, Allergan’s Country Lead, said: "It is a very safe and less time-consuming alternative to the more traditional glaucoma surgery. XEN is also more cost-effective than using more than one type of glaucoma eye drops per patient".

Read 3711 times

Vivian

Highlights

Join

Connect with other Medical Professionals on fb in a closed facebook group

Login

Top
We use cookies to improve our website. By continuing to use this website, you are giving consent to cookies being used. More details…